PhaseBio Pharmaceuticals Inc
PHASDelisted Dec 21, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001169245
PhaseBio Pharmaceuticals Inc was delisted on Dec 21, 2022; its insiders filed their last Form 4 on May 19, 2023; 39 institutions reported holding it in 13F filings for Q3 2022, worth $3.90M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in PhaseBio Pharmaceuticals Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 62
- +7 vs. Q2 2021
- Shares held
- 30.8M
- +2.00M (+6.9%) vs. Q2 2021
- Total value
- $95.9M
- −$11.4M (−10.6%) vs. Q2 2021
- New holders
- 13
- 23 more added
- Sold out
- 6
- 15 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PHAS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 5 | $15.6K |
| Q3 2022 | 39 | $3.90M |
| Q2 2022 | 50 | $14.1M |
| Q1 2022 | 57 | $38.8M |
| Q4 2021 | 52 | $73.5M |
| Q3 2021 | 62 | $95.9M |
| Q2 2021 | 56 | $113.3M |
| Q1 2021 | 62 | $110.3M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding PhaseBio Pharmaceuticals Inc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 6,643,704 | $20.7M | 0.26% | 00.0% | Unchanged |
| Avidity Partners Management LP | 4,405,000 | $13.7M | 0.35% | +90,000+2.1% | Added |
| Wellington Management Group LLP | 4,024,658 | $12.5M | 0.00% | −515,239−11.3% | Reduced |
| Ra Capital Management, L.P. | 2,850,000 | $8.86M | 0.12% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,874,573 | $5.83M | 0.00% | +5,909+0.3% | Added |
| Rock Springs Capital Management LP | 1,843,764 | $5.73M | 0.12% | 00.0% | Unchanged |
| Johnson & Johnson | 1,607,044 | $5.00M | 0.44% | +1,607,044 | New |
| Endurant Capital Management LP | 1,132,523 | $3.52M | 1.07% | −997,186−46.8% | Reduced |
| Candriam Luxembourg S.C.A. | 1,081,258 | $3.36M | 0.02% | +461,824+74.6% | Added |
| Altium Capital Management LP | 775,000 | $2.41M | 0.64% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 603,042 | $1.88M | 0.50% | 00.0% | Unchanged |
| BlackRock Inc. | 519,359 | $1.61M | 0.00% | +32,335+6.6% | Added |
| Eversept Partners, LP | 300,000 | $933.0K | 0.07% | +300,000 | New |
| Millennium Management LLC | 299,816 | $932.0K | 0.00% | +92,273+44.5% | Added |
| Stifel Financial Corp | 292,840 | $911.0K | 0.00% | +30,147+11.5% | Added |
| Geode Capital Management, LLC | 280,589 | $872.0K | 0.00% | +84,729+43.3% | Added |
| Caas Capital Management LP | 263,172 | $818.0K | 0.06% | +263,172 | New |
| Platform Technology Partners | 229,223 | $713.0K | 0.32% | −150−0.1% | Reduced |
| Marshall Wace, LLP | 218,877 | $681.0K | 0.00% | +218,877 | New |
| Bridgeway Capital Management, LLC | 205,600 | $639.0K | 0.01% | +117,000+132.1% | Added |
| Susquehanna International Group, LLP | 180,359 | $561.0K | 0.00% | +123,075+214.9% | Added |
| OrbiMed Advisors LLC | 177,113 | $551.0K | 0.01% | +177,113 | New |
| Morgan Stanley | 149,162 | $464.0K | 0.00% | +20,081+15.6% | Added |
| Renaissance Technologies LLC | 100,566 | $313.0K | 0.00% | +100,566 | New |
| Resources Investment Advisors, LLC. | 88,150 | $274.0K | 0.01% | +35,700+68.1% | Added |
| State Street Corp | 79,078 | $246.0K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 78,547 | $244.0K | 0.00% | +60,873+344.4% | Added |
| Northern Trust Corp | 62,706 | $195.0K | 0.00% | −1,775−2.8% | Reduced |
| Jump Financial, LLC | 43,867 | $136.0K | 0.01% | +43,867 | New |
| Boothbay Fund Management, LLC | 40,727 | $127.0K | 0.01% | +163+0.4% | Added |
| Hamilton Lane Advisors LLC | 34,208 | $106.0K | 0.02% | 00.0% | Unchanged |
| Barclays PLC | 32,623 | $101.0K | 0.00% | −1,147−3.4% | Reduced |
| Jacobs Levy Equity Management, Inc | 31,324 | $97.0K | 0.00% | +31,324 | New |
| Goldman Sachs Group Inc | 30,616 | $95.0K | 0.00% | −20,681−40.3% | Reduced |
| Occudo Quantitative Strategies LP | 29,448 | $92.0K | 0.01% | +14,533+97.4% | Added |
| HRT Financial LP | 28,286 | $87.0K | 0.00% | +28,286 | New |
| Pura Vida Investments, LLC | 27,944 | $87.0K | 0.01% | +27,944 | New |
| Squarepoint Ops LLC | 27,083 | $84.0K | 0.00% | +6,216+29.8% | Added |
| Snowden Capital Advisors LLC | 21,000 | $65.3K | 0.00% | +1,000+5.0% | Added |
| Blair William & Co | 18,000 | $56.0K | 0.00% | +1,000+5.9% | Added |
| ETF Managers Group, LLC | 17,172 | $54.0K | 0.00% | +2,993+21.1% | Added |
| Citadel Advisors LLC | 13,907 | $43.0K | 0.00% | −26,477−65.6% | Reduced |
| Cubist Systematic Strategies, LLC | 13,137 | $41.0K | 0.00% | −5,995−31.3% | Reduced |
| Acadian Asset Management LLC | 12,550 | $39.0K | 0.00% | +12,550 | New |
| XTX Topco Ltd | 11,215 | $35.0K | 0.01% | +11,215 | New |
| Ergoteles LLC | 10,881 | $34.0K | 0.00% | −58,919−84.4% | Reduced |
| Wells Fargo & Company | 10,597 | $33.0K | 0.00% | +8,793+487.4% | Added |
| Tower Research Capital LLC (TRC) | 8,122 | $26.0K | 0.00% | +4,557+127.8% | Added |
| Bank of America Corp | 5,496 | $17.0K | 0.00% | −1,569−22.2% | Reduced |
| Advisor Group Holdings, Inc. | 3,825 | $12.0K | 0.00% | +1,000+35.4% | Added |
| Capital Advisory Group Advisory Services, LLC | 2,800 | $9.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,000 | $6.00K | 0.00% | −956−32.3% | Reduced |
| Group One Trading, L.P. | 1,700 | $5.00K | 0.00% | +500+41.7% | Added |
| UBS Group AG | 1,000 | $3.00K | 0.00% | −3,087−75.5% | Reduced |
| Cutler Group LP | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 380 | $1.18K | 0.00% | +79+26.2% | Added |
| Simplex Trading, LLC | 417 | $1.00K | 0.00% | −100−19.3% | Reduced |
| Kistler-Tiffany Companies, LLC | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Point72 Hong Kong Ltd | 164 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 316 | $1.00K | 0.00% | +316 | New |
| JPMorgan Chase & Co | 17 | $0 | 0.00% | −76,589−100.0% | Reduced |
| O'Shaughnessy Asset Management, LLC | 2 | $0 | 0.00% | −120−98.4% | Reduced |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −186,031−100.0% | Sold out |
| Tibra Equities Europe Ltd | 0 | $0 | 0.00% | −91,200−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −17,190−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −10,254−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −521−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Johnson & Johnson Innovation - JJDC, Inc. | – | – | – | – | Not filed |